nodes	percent_of_prediction	percent_of_DWPC	metapath
Amoxapine—Drug fever—Methimazole—Graves' disease	0.102	0.127	CcSEcCtD
Amoxapine—Epigastric distress—Methimazole—Graves' disease	0.0879	0.109	CcSEcCtD
Amoxapine—Drug fever—Propylthiouracil—Graves' disease	0.0868	0.108	CcSEcCtD
Amoxapine—Epigastric distress—Propylthiouracil—Graves' disease	0.0747	0.0927	CcSEcCtD
Amoxapine—Vasculitis—Propylthiouracil—Graves' disease	0.0297	0.0368	CcSEcCtD
Amoxapine—Drowsiness—Methimazole—Graves' disease	0.0191	0.0236	CcSEcCtD
Amoxapine—Jaundice—Methimazole—Graves' disease	0.0186	0.023	CcSEcCtD
Amoxapine—Agranulocytosis—Methimazole—Graves' disease	0.0178	0.0221	CcSEcCtD
Amoxapine—Hepatitis—Methimazole—Graves' disease	0.0171	0.0212	CcSEcCtD
Amoxapine—Drowsiness—Propylthiouracil—Graves' disease	0.0162	0.0201	CcSEcCtD
Amoxapine—Jaundice—Propylthiouracil—Graves' disease	0.0158	0.0196	CcSEcCtD
Amoxapine—Agranulocytosis—Propylthiouracil—Graves' disease	0.0151	0.0188	CcSEcCtD
Amoxapine—Alopecia—Methimazole—Graves' disease	0.0151	0.0188	CcSEcCtD
Amoxapine—Hepatitis—Propylthiouracil—Graves' disease	0.0146	0.018	CcSEcCtD
Amoxapine—Leukopenia—Methimazole—Graves' disease	0.0133	0.0165	CcSEcCtD
Amoxapine—Alopecia—Propylthiouracil—Graves' disease	0.0129	0.0159	CcSEcCtD
Amoxapine—Dysgeusia—Propylthiouracil—Graves' disease	0.0124	0.0154	CcSEcCtD
Amoxapine—Oedema—Methimazole—Graves' disease	0.0122	0.0151	CcSEcCtD
Amoxapine—Thrombocytopenia—Methimazole—Graves' disease	0.0119	0.0148	CcSEcCtD
Amoxapine—Leukopenia—Propylthiouracil—Graves' disease	0.0113	0.0141	CcSEcCtD
Amoxapine—Paraesthesia—Methimazole—Graves' disease	0.0109	0.0135	CcSEcCtD
Amoxapine—Somnolence—Methimazole—Graves' disease	0.0108	0.0134	CcSEcCtD
Amoxapine—Dyspepsia—Methimazole—Graves' disease	0.0107	0.0133	CcSEcCtD
Amoxapine—Oedema—Propylthiouracil—Graves' disease	0.0103	0.0128	CcSEcCtD
Amoxapine—Thrombocytopenia—Propylthiouracil—Graves' disease	0.0101	0.0126	CcSEcCtD
Amoxapine—Urticaria—Methimazole—Graves' disease	0.00966	0.012	CcSEcCtD
Amoxapine—Body temperature increased—Methimazole—Graves' disease	0.00961	0.0119	CcSEcCtD
Amoxapine—Paraesthesia—Propylthiouracil—Graves' disease	0.00928	0.0115	CcSEcCtD
Amoxapine—Somnolence—Propylthiouracil—Graves' disease	0.00919	0.0114	CcSEcCtD
Amoxapine—Dyspepsia—Propylthiouracil—Graves' disease	0.0091	0.0113	CcSEcCtD
Amoxapine—Pruritus—Methimazole—Graves' disease	0.0086	0.0107	CcSEcCtD
Amoxapine—Urticaria—Propylthiouracil—Graves' disease	0.00821	0.0102	CcSEcCtD
Amoxapine—Body temperature increased—Propylthiouracil—Graves' disease	0.00817	0.0101	CcSEcCtD
Amoxapine—Vomiting—Methimazole—Graves' disease	0.00773	0.00959	CcSEcCtD
Amoxapine—Rash—Methimazole—Graves' disease	0.00767	0.00951	CcSEcCtD
Amoxapine—Dermatitis—Methimazole—Graves' disease	0.00766	0.0095	CcSEcCtD
Amoxapine—Headache—Methimazole—Graves' disease	0.00762	0.00944	CcSEcCtD
Amoxapine—Chlordiazepoxide—GABRA3—Graves' disease	0.00752	0.21	CrCbGaD
Amoxapine—Pruritus—Propylthiouracil—Graves' disease	0.00731	0.00907	CcSEcCtD
Amoxapine—Nausea—Methimazole—Graves' disease	0.00722	0.00896	CcSEcCtD
Amoxapine—Vomiting—Propylthiouracil—Graves' disease	0.00657	0.00815	CcSEcCtD
Amoxapine—Rash—Propylthiouracil—Graves' disease	0.00652	0.00808	CcSEcCtD
Amoxapine—Dermatitis—Propylthiouracil—Graves' disease	0.00651	0.00808	CcSEcCtD
Amoxapine—Headache—Propylthiouracil—Graves' disease	0.00648	0.00803	CcSEcCtD
Amoxapine—Nausea—Propylthiouracil—Graves' disease	0.00614	0.00761	CcSEcCtD
Amoxapine—Estazolam—GABRA3—Graves' disease	0.00546	0.152	CrCbGaD
Amoxapine—Fludiazepam—GABRA3—Graves' disease	0.00514	0.143	CrCbGaD
Amoxapine—Prazepam—GABRA3—Graves' disease	0.00502	0.14	CrCbGaD
Amoxapine—Oxazepam—GABRA3—Graves' disease	0.00453	0.126	CrCbGaD
Amoxapine—Temazepam—GABRA3—Graves' disease	0.00448	0.125	CrCbGaD
Amoxapine—Diazepam—GABRA3—Graves' disease	0.00372	0.104	CrCbGaD
Amoxapine—GABRA1—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.00112	0.00712	CbGpPWpGaD
Amoxapine—HRH4—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.00111	0.00705	CbGpPWpGaD
Amoxapine—SLC6A2—Monoamine Transport—IL1B—Graves' disease	0.00109	0.0069	CbGpPWpGaD
Amoxapine—HTR3A—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000982	0.00623	CbGpPWpGaD
Amoxapine—SLC6A3—Monoamine Transport—IL1B—Graves' disease	0.000964	0.00611	CbGpPWpGaD
Amoxapine—SLC6A4—Monoamine Transport—TNF—Graves' disease	0.000918	0.00582	CbGpPWpGaD
Amoxapine—HRH4—G alpha (i) signalling events—CXCL10—Graves' disease	0.000903	0.00573	CbGpPWpGaD
Amoxapine—SLC6A3—Neuronal System—GABRA3—Graves' disease	0.000868	0.00551	CbGpPWpGaD
Amoxapine—GABRA1—Neuronal System—GABRA3—Graves' disease	0.00086	0.00546	CbGpPWpGaD
Amoxapine—HRH4—GPCR ligand binding—TSHR—Graves' disease	0.000846	0.00537	CbGpPWpGaD
Amoxapine—SLC6A2—Monoamine Transport—TNF—Graves' disease	0.000789	0.00501	CbGpPWpGaD
Amoxapine—HRH4—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000718	0.00455	CbGpPWpGaD
Amoxapine—SLC6A3—Monoamine Transport—TNF—Graves' disease	0.000699	0.00443	CbGpPWpGaD
Amoxapine—HTR6—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000661	0.00419	CbGpPWpGaD
Amoxapine—HTR7—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.00066	0.00419	CbGpPWpGaD
Amoxapine—HTR1B—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000642	0.00407	CbGpPWpGaD
Amoxapine—DRD4—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000632	0.00401	CbGpPWpGaD
Amoxapine—HTR2B—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000603	0.00383	CbGpPWpGaD
Amoxapine—HTR3A—SIDS Susceptibility Pathways—IL1B—Graves' disease	0.000571	0.00362	CbGpPWpGaD
Amoxapine—DRD1—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000569	0.00361	CbGpPWpGaD
Amoxapine—DRD3—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000561	0.00356	CbGpPWpGaD
Amoxapine—HRH4—GPCR ligand binding—CXCL10—Graves' disease	0.000547	0.00347	CbGpPWpGaD
Amoxapine—SLC6A2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000527	0.00334	CbGpPWpGaD
Amoxapine—HTR1B—G alpha (i) signalling events—CXCL10—Graves' disease	0.000522	0.00331	CbGpPWpGaD
Amoxapine—DRD4—G alpha (i) signalling events—CXCL10—Graves' disease	0.000514	0.00326	CbGpPWpGaD
Amoxapine—HTR6—GPCR ligand binding—TSHR—Graves' disease	0.000503	0.00319	CbGpPWpGaD
Amoxapine—HTR7—GPCR ligand binding—TSHR—Graves' disease	0.000503	0.00319	CbGpPWpGaD
Amoxapine—SLC6A4—Circadian rythm related genes—FAS—Graves' disease	0.000497	0.00315	CbGpPWpGaD
Amoxapine—HTR1A—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000489	0.0031	CbGpPWpGaD
Amoxapine—HTR1B—GPCR ligand binding—TSHR—Graves' disease	0.000489	0.0031	CbGpPWpGaD
Amoxapine—HTR2C—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000487	0.00309	CbGpPWpGaD
Amoxapine—DRD4—GPCR ligand binding—TSHR—Graves' disease	0.000481	0.00305	CbGpPWpGaD
Amoxapine—HRH4—GPCR downstream signaling—TSHR—Graves' disease	0.000478	0.00303	CbGpPWpGaD
Amoxapine—HTR7—Circadian rythm related genes—FAS—Graves' disease	0.000467	0.00296	CbGpPWpGaD
Amoxapine—SLC6A3—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000467	0.00296	CbGpPWpGaD
Amoxapine—GABRA1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000463	0.00293	CbGpPWpGaD
Amoxapine—HTR2B—GPCR ligand binding—TSHR—Graves' disease	0.000459	0.00291	CbGpPWpGaD
Amoxapine—DRD3—G alpha (i) signalling events—CXCL10—Graves' disease	0.000456	0.00289	CbGpPWpGaD
Amoxapine—DRD4—Circadian rythm related genes—FAS—Graves' disease	0.000447	0.00284	CbGpPWpGaD
Amoxapine—HRH4—Signaling by GPCR—TSHR—Graves' disease	0.000434	0.00275	CbGpPWpGaD
Amoxapine—DRD1—GPCR ligand binding—TSHR—Graves' disease	0.000433	0.00275	CbGpPWpGaD
Amoxapine—DRD2—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.00043	0.00272	CbGpPWpGaD
Amoxapine—DRD3—GPCR ligand binding—TSHR—Graves' disease	0.000427	0.00271	CbGpPWpGaD
Amoxapine—HTR6—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000427	0.00271	CbGpPWpGaD
Amoxapine—HTR7—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000427	0.00271	CbGpPWpGaD
Amoxapine—HTR2A—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000423	0.00268	CbGpPWpGaD
Amoxapine—HRH1—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000422	0.00267	CbGpPWpGaD
Amoxapine—CHRM1—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.00042	0.00267	CbGpPWpGaD
Amoxapine—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000415	0.00263	CbGpPWpGaD
Amoxapine—HTR3A—SIDS Susceptibility Pathways—TNF—Graves' disease	0.000414	0.00263	CbGpPWpGaD
Amoxapine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000414	0.00262	CbGpPWpGaD
Amoxapine—DRD4—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000408	0.00259	CbGpPWpGaD
Amoxapine—DRD1—Circadian rythm related genes—FAS—Graves' disease	0.000403	0.00255	CbGpPWpGaD
Amoxapine—HTR1A—G alpha (i) signalling events—CXCL10—Graves' disease	0.000398	0.00252	CbGpPWpGaD
Amoxapine—DRD3—Circadian rythm related genes—FAS—Graves' disease	0.000397	0.00252	CbGpPWpGaD
Amoxapine—HTR2B—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.00039	0.00247	CbGpPWpGaD
Amoxapine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000385	0.00244	CbGpPWpGaD
Amoxapine—HTR1A—GPCR ligand binding—TSHR—Graves' disease	0.000373	0.00236	CbGpPWpGaD
Amoxapine—HTR2C—GPCR ligand binding—TSHR—Graves' disease	0.000371	0.00235	CbGpPWpGaD
Amoxapine—DRD1—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000368	0.00233	CbGpPWpGaD
Amoxapine—DRD3—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000363	0.0023	CbGpPWpGaD
Amoxapine—SLC6A4—SIDS Susceptibility Pathways—IL1B—Graves' disease	0.000356	0.00226	CbGpPWpGaD
Amoxapine—DRD2—G alpha (i) signalling events—CXCL10—Graves' disease	0.000349	0.00221	CbGpPWpGaD
Amoxapine—DRD2—GPCR ligand binding—TSHR—Graves' disease	0.000327	0.00207	CbGpPWpGaD
Amoxapine—HTR6—GPCR ligand binding—CXCL10—Graves' disease	0.000325	0.00206	CbGpPWpGaD
Amoxapine—HTR7—GPCR ligand binding—CXCL10—Graves' disease	0.000325	0.00206	CbGpPWpGaD
Amoxapine—HTR2A—GPCR ligand binding—TSHR—Graves' disease	0.000322	0.00204	CbGpPWpGaD
Amoxapine—HRH1—GPCR ligand binding—TSHR—Graves' disease	0.000321	0.00204	CbGpPWpGaD
Amoxapine—CHRM1—GPCR ligand binding—TSHR—Graves' disease	0.00032	0.00203	CbGpPWpGaD
Amoxapine—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000316	0.002	CbGpPWpGaD
Amoxapine—HTR1B—GPCR ligand binding—CXCL10—Graves' disease	0.000316	0.002	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR ligand binding—TSHR—Graves' disease	0.000315	0.002	CbGpPWpGaD
Amoxapine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000315	0.00199	CbGpPWpGaD
Amoxapine—ADRA2A—G alpha (i) signalling events—CXCL10—Graves' disease	0.000313	0.00198	CbGpPWpGaD
Amoxapine—DRD4—GPCR ligand binding—CXCL10—Graves' disease	0.000311	0.00197	CbGpPWpGaD
Amoxapine—HRH4—GPCR downstream signaling—CXCL10—Graves' disease	0.000309	0.00196	CbGpPWpGaD
Amoxapine—DRD2—Circadian rythm related genes—FAS—Graves' disease	0.000304	0.00193	CbGpPWpGaD
Amoxapine—CHRM1—Circadian rythm related genes—FAS—Graves' disease	0.000298	0.00189	CbGpPWpGaD
Amoxapine—HTR2B—GPCR ligand binding—CXCL10—Graves' disease	0.000297	0.00188	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR ligand binding—TSHR—Graves' disease	0.000293	0.00186	CbGpPWpGaD
Amoxapine—HTR6—GPCR downstream signaling—TSHR—Graves' disease	0.000284	0.0018	CbGpPWpGaD
Amoxapine—HTR7—GPCR downstream signaling—TSHR—Graves' disease	0.000284	0.0018	CbGpPWpGaD
Amoxapine—HRH4—Signaling by GPCR—CXCL10—Graves' disease	0.000281	0.00178	CbGpPWpGaD
Amoxapine—DRD1—GPCR ligand binding—CXCL10—Graves' disease	0.00028	0.00178	CbGpPWpGaD
Amoxapine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000278	0.00176	CbGpPWpGaD
Amoxapine—HTR1B—GPCR downstream signaling—TSHR—Graves' disease	0.000276	0.00175	CbGpPWpGaD
Amoxapine—DRD3—GPCR ligand binding—CXCL10—Graves' disease	0.000276	0.00175	CbGpPWpGaD
Amoxapine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000273	0.00173	CbGpPWpGaD
Amoxapine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000273	0.00173	CbGpPWpGaD
Amoxapine—DRD4—GPCR downstream signaling—TSHR—Graves' disease	0.000272	0.00172	CbGpPWpGaD
Amoxapine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000272	0.00172	CbGpPWpGaD
Amoxapine—GABRA1—SIDS Susceptibility Pathways—IL1B—Graves' disease	0.000269	0.00171	CbGpPWpGaD
Amoxapine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000267	0.0017	CbGpPWpGaD
Amoxapine—HTR2B—GPCR downstream signaling—TSHR—Graves' disease	0.00026	0.00165	CbGpPWpGaD
Amoxapine—SLC6A4—SIDS Susceptibility Pathways—TNF—Graves' disease	0.000258	0.00164	CbGpPWpGaD
Amoxapine—HTR6—Signaling by GPCR—TSHR—Graves' disease	0.000258	0.00164	CbGpPWpGaD
Amoxapine—HTR7—Signaling by GPCR—TSHR—Graves' disease	0.000258	0.00164	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—TSHR—Graves' disease	0.000257	0.00163	CbGpPWpGaD
Amoxapine—HTR1B—Signaling by GPCR—TSHR—Graves' disease	0.000251	0.00159	CbGpPWpGaD
Amoxapine—ADRA2A—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	0.000251	0.00159	CbGpPWpGaD
Amoxapine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000248	0.00158	CbGpPWpGaD
Amoxapine—HTR1A—SIDS Susceptibility Pathways—IL1B—Graves' disease	0.000248	0.00157	CbGpPWpGaD
Amoxapine—DRD4—Signaling by GPCR—TSHR—Graves' disease	0.000247	0.00157	CbGpPWpGaD
Amoxapine—DRD1—GPCR downstream signaling—TSHR—Graves' disease	0.000245	0.00155	CbGpPWpGaD
Amoxapine—DRD3—GPCR downstream signaling—TSHR—Graves' disease	0.000242	0.00153	CbGpPWpGaD
Amoxapine—HTR1A—GPCR ligand binding—CXCL10—Graves' disease	0.000241	0.00153	CbGpPWpGaD
Amoxapine—HTR2C—GPCR ligand binding—CXCL10—Graves' disease	0.000239	0.00152	CbGpPWpGaD
Amoxapine—HRH4—GPCR downstream signaling—IL2RA—Graves' disease	0.000236	0.0015	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—TSHR—Graves' disease	0.000236	0.0015	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—TSHR—Graves' disease	0.000222	0.00141	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—TSHR—Graves' disease	0.000219	0.00139	CbGpPWpGaD
Amoxapine—HRH4—Signaling by GPCR—IL2RA—Graves' disease	0.000215	0.00136	CbGpPWpGaD
Amoxapine—HTR2A—SIDS Susceptibility Pathways—IL1B—Graves' disease	0.000214	0.00136	CbGpPWpGaD
Amoxapine—DRD2—GPCR ligand binding—CXCL10—Graves' disease	0.000211	0.00134	CbGpPWpGaD
Amoxapine—HTR1A—GPCR downstream signaling—TSHR—Graves' disease	0.000211	0.00134	CbGpPWpGaD
Amoxapine—HTR2C—GPCR downstream signaling—TSHR—Graves' disease	0.000209	0.00133	CbGpPWpGaD
Amoxapine—HTR2A—GPCR ligand binding—CXCL10—Graves' disease	0.000208	0.00132	CbGpPWpGaD
Amoxapine—HRH1—GPCR ligand binding—CXCL10—Graves' disease	0.000208	0.00132	CbGpPWpGaD
Amoxapine—CHRM1—GPCR ligand binding—CXCL10—Graves' disease	0.000207	0.00131	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR ligand binding—CXCL10—Graves' disease	0.000204	0.00129	CbGpPWpGaD
Amoxapine—GABRA1—SIDS Susceptibility Pathways—TNF—Graves' disease	0.000195	0.00124	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—TSHR—Graves' disease	0.000191	0.00121	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—TSHR—Graves' disease	0.00019	0.00121	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR ligand binding—CXCL10—Graves' disease	0.000189	0.0012	CbGpPWpGaD
Amoxapine—DRD2—GPCR downstream signaling—TSHR—Graves' disease	0.000185	0.00117	CbGpPWpGaD
Amoxapine—HTR6—GPCR downstream signaling—CXCL10—Graves' disease	0.000184	0.00117	CbGpPWpGaD
Amoxapine—HTR7—GPCR downstream signaling—CXCL10—Graves' disease	0.000184	0.00116	CbGpPWpGaD
Amoxapine—HTR2A—GPCR downstream signaling—TSHR—Graves' disease	0.000182	0.00115	CbGpPWpGaD
Amoxapine—HRH1—GPCR downstream signaling—TSHR—Graves' disease	0.000181	0.00115	CbGpPWpGaD
Amoxapine—CHRM1—GPCR downstream signaling—TSHR—Graves' disease	0.000181	0.00115	CbGpPWpGaD
Amoxapine—HTR1A—SIDS Susceptibility Pathways—TNF—Graves' disease	0.00018	0.00114	CbGpPWpGaD
Amoxapine—HTR1B—GPCR downstream signaling—CXCL10—Graves' disease	0.000179	0.00113	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR downstream signaling—TSHR—Graves' disease	0.000178	0.00113	CbGpPWpGaD
Amoxapine—DRD4—GPCR downstream signaling—CXCL10—Graves' disease	0.000176	0.00111	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—GC—Graves' disease	0.000169	0.00107	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—TSHR—Graves' disease	0.000168	0.00106	CbGpPWpGaD
Amoxapine—HTR2B—GPCR downstream signaling—CXCL10—Graves' disease	0.000168	0.00106	CbGpPWpGaD
Amoxapine—HTR6—Signaling by GPCR—CXCL10—Graves' disease	0.000167	0.00106	CbGpPWpGaD
Amoxapine—HTR7—Signaling by GPCR—CXCL10—Graves' disease	0.000167	0.00106	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—CXCL10—Graves' disease	0.000166	0.00105	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR downstream signaling—TSHR—Graves' disease	0.000165	0.00105	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—TSHR—Graves' disease	0.000165	0.00105	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—TSHR—Graves' disease	0.000165	0.00105	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—TSHR—Graves' disease	0.000164	0.00104	CbGpPWpGaD
Amoxapine—HTR1B—Signaling by GPCR—CXCL10—Graves' disease	0.000162	0.00103	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—TSHR—Graves' disease	0.000162	0.00103	CbGpPWpGaD
Amoxapine—DRD4—Signaling by GPCR—CXCL10—Graves' disease	0.00016	0.00101	CbGpPWpGaD
Amoxapine—DRD1—GPCR downstream signaling—CXCL10—Graves' disease	0.000158	0.001	CbGpPWpGaD
Amoxapine—DRD3—GPCR downstream signaling—CXCL10—Graves' disease	0.000156	0.00099	CbGpPWpGaD
Amoxapine—HTR2A—SIDS Susceptibility Pathways—TNF—Graves' disease	0.000156	0.000987	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—TSHR—Graves' disease	0.000153	0.000968	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—TSHR—Graves' disease	0.000152	0.000966	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—CXCL10—Graves' disease	0.000152	0.000966	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—TSHR—Graves' disease	0.00015	0.000953	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—TSHR—Graves' disease	0.000148	0.00094	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—TSHR—Graves' disease	0.000146	0.000925	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—CXCL10—Graves' disease	0.000144	0.000911	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—CXCL10—Graves' disease	0.000142	0.000899	CbGpPWpGaD
Amoxapine—HTR6—GPCR downstream signaling—IL2RA—Graves' disease	0.00014	0.000891	CbGpPWpGaD
Amoxapine—HTR7—GPCR downstream signaling—IL2RA—Graves' disease	0.00014	0.00089	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—TSHR—Graves' disease	0.000139	0.000883	CbGpPWpGaD
Amoxapine—HTR1B—GPCR downstream signaling—IL2RA—Graves' disease	0.000136	0.000866	CbGpPWpGaD
Amoxapine—HTR1A—GPCR downstream signaling—CXCL10—Graves' disease	0.000136	0.000863	CbGpPWpGaD
Amoxapine—HTR2C—GPCR downstream signaling—CXCL10—Graves' disease	0.000135	0.000858	CbGpPWpGaD
Amoxapine—DRD4—GPCR downstream signaling—IL2RA—Graves' disease	0.000134	0.000852	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—TSHR—Graves' disease	0.000131	0.000833	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—TSHR—Graves' disease	0.00013	0.000822	CbGpPWpGaD
Amoxapine—ADRA2A—Hemostasis—IL2RA—Graves' disease	0.000129	0.00082	CbGpPWpGaD
Amoxapine—HTR2B—GPCR downstream signaling—IL2RA—Graves' disease	0.000128	0.000813	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—B3GNT2—Graves' disease	0.000128	0.000812	CbGpPWpGaD
Amoxapine—HTR6—Signaling by GPCR—IL2RA—Graves' disease	0.000128	0.000809	CbGpPWpGaD
Amoxapine—HTR7—Signaling by GPCR—IL2RA—Graves' disease	0.000127	0.000808	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—IL2RA—Graves' disease	0.000127	0.000804	CbGpPWpGaD
Amoxapine—HTR1B—Signaling by GPCR—IL2RA—Graves' disease	0.000124	0.000786	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—CXCL10—Graves' disease	0.000124	0.000783	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—CXCL10—Graves' disease	0.000123	0.000779	CbGpPWpGaD
Amoxapine—DRD4—Signaling by GPCR—IL2RA—Graves' disease	0.000122	0.000773	CbGpPWpGaD
Amoxapine—DRD1—GPCR downstream signaling—IL2RA—Graves' disease	0.000121	0.000767	CbGpPWpGaD
Amoxapine—DRD2—GPCR downstream signaling—CXCL10—Graves' disease	0.000119	0.000757	CbGpPWpGaD
Amoxapine—DRD3—GPCR downstream signaling—IL2RA—Graves' disease	0.000119	0.000757	CbGpPWpGaD
Amoxapine—HTR2A—GPCR downstream signaling—CXCL10—Graves' disease	0.000118	0.000745	CbGpPWpGaD
Amoxapine—HRH1—GPCR downstream signaling—CXCL10—Graves' disease	0.000117	0.000744	CbGpPWpGaD
Amoxapine—CHRM1—GPCR downstream signaling—CXCL10—Graves' disease	0.000117	0.000741	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—IL2RA—Graves' disease	0.000116	0.000738	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR downstream signaling—CXCL10—Graves' disease	0.000115	0.00073	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—TSHR—Graves' disease	0.000113	0.000716	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—TSHR—Graves' disease	0.000112	0.000713	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—GC—Graves' disease	0.00011	0.000699	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—IL2RA—Graves' disease	0.00011	0.000696	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—CXCL10—Graves' disease	0.000108	0.000688	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—IL2RA—Graves' disease	0.000108	0.000687	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR downstream signaling—CXCL10—Graves' disease	0.000107	0.000678	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—CXCL10—Graves' disease	0.000107	0.000677	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—CXCL10—Graves' disease	0.000107	0.000675	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—CXCL10—Graves' disease	0.000106	0.000673	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—CXCL10—Graves' disease	0.000105	0.000663	CbGpPWpGaD
Amoxapine—HTR1A—GPCR downstream signaling—IL2RA—Graves' disease	0.000104	0.000659	CbGpPWpGaD
Amoxapine—HTR2C—GPCR downstream signaling—IL2RA—Graves' disease	0.000103	0.000656	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—TSHR—Graves' disease	9.92e-05	0.000629	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—CXCL10—Graves' disease	9.86e-05	0.000625	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—CXCL10—Graves' disease	9.85e-05	0.000625	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—TSHR—Graves' disease	9.76e-05	0.000619	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—TSHR—Graves' disease	9.74e-05	0.000617	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—CXCL10—Graves' disease	9.71e-05	0.000616	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—TSHR—Graves' disease	9.7e-05	0.000615	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—CXCL10—Graves' disease	9.58e-05	0.000608	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—TSHR—Graves' disease	9.55e-05	0.000606	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—IL2RA—Graves' disease	9.44e-05	0.000599	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—CXCL10—Graves' disease	9.43e-05	0.000598	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—IL2RA—Graves' disease	9.39e-05	0.000596	CbGpPWpGaD
Amoxapine—DRD2—GPCR downstream signaling—IL2RA—Graves' disease	9.13e-05	0.000579	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—CXCL10—Graves' disease	9e-05	0.000571	CbGpPWpGaD
Amoxapine—HTR2A—GPCR downstream signaling—IL2RA—Graves' disease	8.98e-05	0.00057	CbGpPWpGaD
Amoxapine—HRH1—GPCR downstream signaling—IL2RA—Graves' disease	8.96e-05	0.000568	CbGpPWpGaD
Amoxapine—CHRM1—GPCR downstream signaling—IL2RA—Graves' disease	8.93e-05	0.000567	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—TSHR—Graves' disease	8.88e-05	0.000563	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR downstream signaling—IL2RA—Graves' disease	8.8e-05	0.000558	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—CXCL10—Graves' disease	8.49e-05	0.000538	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—CXCL10—Graves' disease	8.37e-05	0.000531	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—B3GNT2—Graves' disease	8.35e-05	0.000529	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—IL2RA—Graves' disease	8.29e-05	0.000526	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR downstream signaling—IL2RA—Graves' disease	8.17e-05	0.000518	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—IL2RA—Graves' disease	8.16e-05	0.000517	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—IL2RA—Graves' disease	8.14e-05	0.000516	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—IL2RA—Graves' disease	8.11e-05	0.000515	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—IL2RA—Graves' disease	7.99e-05	0.000507	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—IL2RA—Graves' disease	7.54e-05	0.000478	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—IL2RA—Graves' disease	7.53e-05	0.000477	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—IL2RA—Graves' disease	7.42e-05	0.000471	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—IL2RA—Graves' disease	7.32e-05	0.000464	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—CXCL10—Graves' disease	7.3e-05	0.000463	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—CXCL10—Graves' disease	7.26e-05	0.00046	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—IL2RA—Graves' disease	7.21e-05	0.000457	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—IL2RA—Graves' disease	6.88e-05	0.000436	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—IL2RA—Graves' disease	6.49e-05	0.000411	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CXCL10—Graves' disease	6.41e-05	0.000406	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—IL2RA—Graves' disease	6.4e-05	0.000406	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CXCL10—Graves' disease	6.3e-05	0.0004	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CXCL10—Graves' disease	6.29e-05	0.000399	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CXCL10—Graves' disease	6.27e-05	0.000398	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CXCL10—Graves' disease	6.17e-05	0.000391	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CXCL10—Graves' disease	5.74e-05	0.000364	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—IL2RA—Graves' disease	5.58e-05	0.000354	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—IL2RA—Graves' disease	5.55e-05	0.000352	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—IL2RA—Graves' disease	4.9e-05	0.000311	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—IL2RA—Graves' disease	4.82e-05	0.000306	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—IL2RA—Graves' disease	4.81e-05	0.000305	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—IL2RA—Graves' disease	4.79e-05	0.000304	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—IL2RA—Graves' disease	4.72e-05	0.000299	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—IL2RA—Graves' disease	4.38e-05	0.000278	CbGpPWpGaD
